195 related articles for article (PubMed ID: 32738597)
1. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
[TBL] [Abstract][Full Text] [Related]
2. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
Xu C; Zeng H; Fan J; Huang W; Yu X; Li S; Wang F; Long X
BMC Cancer; 2022 Mar; 22(1):264. PubMed ID: 35279104
[TBL] [Abstract][Full Text] [Related]
3. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
Lin P; Guo YN; Shi L; Li XJ; Yang H; He Y; Li Q; Dang YW; Wei KL; Chen G
Aging (Albany NY); 2019 Jan; 11(2):480-500. PubMed ID: 30661062
[TBL] [Abstract][Full Text] [Related]
4. Development of a prognostic index of colon adenocarcinoma based on immunogenomic landscape analysis.
Qiang W; Dai Y; Sun G; Xing X; Sun X
Ann Transl Med; 2020 Mar; 8(6):284. PubMed ID: 32355728
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
Zeng Q; Zhang W; Li X; Lai J; Li Z
Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
Li L; Wang XL; Lei Q; Sun CZ; Xi Y; Chen R; He YW
Sci Rep; 2020 Apr; 10(1):6395. PubMed ID: 32286381
[TBL] [Abstract][Full Text] [Related]
7. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
8. Mining therapeutic and prognostic significance of STATs in renal cell carcinoma with bioinformatics analysis.
Zhou L; Li Y; Li Z; Huang Q
Genomics; 2020 Nov; 112(6):4100-4114. PubMed ID: 32640276
[TBL] [Abstract][Full Text] [Related]
9. Identification of a four immune-related genes signature based on an immunogenomic landscape analysis of clear cell renal cell carcinoma.
Gao X; Yang J; Chen Y
J Cell Physiol; 2020 Dec; 235(12):9834-9850. PubMed ID: 32452055
[TBL] [Abstract][Full Text] [Related]
10. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
[TBL] [Abstract][Full Text] [Related]
11. Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer.
Lin K; Huang J; Luo H; Luo C; Zhu X; Bu F; Xiao H; Xiao L; Zhu Z
Aging (Albany NY); 2020 Mar; 12(7):5832-5857. PubMed ID: 32235004
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
Jin Y; Deng J; Luo B; Zhong Y; Yu S
Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis.
Hou L; Liu X
Genet Res (Camb); 2023; 2023():3898610. PubMed ID: 37065178
[TBL] [Abstract][Full Text] [Related]
14. Construction of exosome-related genes risk model in kidney cell carcinoma predicts prognosis and immune therapy response.
Gao C; Huang W; Su Q; Li J; Wang W; Qi Y; Du E; Zhang Z
Aging (Albany NY); 2024 May; 16(9):7622-7646. PubMed ID: 38728235
[TBL] [Abstract][Full Text] [Related]
15. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
16. Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer.
Feng T; Zhao J; Wei D; Guo P; Yang X; Li Q; Fang Z; Wei Z; Li M; Jiang Y; Luo Y
Front Immunol; 2021; 12():762120. PubMed ID: 34712244
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
19. Development of a prognostic index based on immunogenomic landscape analysis in glioma.
Luo H; Tao C; Wang P; Li J; Huang K; Zhu X
Immun Inflamm Dis; 2021 Jun; 9(2):467-479. PubMed ID: 33503296
[TBL] [Abstract][Full Text] [Related]
20. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
Cao P; Wu JY; Zhang JD; Sun ZJ; Zheng X; Yu BZ; Cao HY; Zhang FL; Gao ZH; Wang W
BMC Cancer; 2022 Jun; 22(1):691. PubMed ID: 35739510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]